Wedescribe two siblings affected by chronic relapsing thrombotic thrombocytopenic purpura from infancy. The elder brother, a 12-year-old boy had 50 such episodes characterized by acute onset of fever, headache, drowsiness, vomiting, dark urine, thrombocytopenia and anemia. The younger sister, a 6-year-old girl, had 8 episodes with the same clinical manifestations. Petechiae and ecchymoses on the extremities were present throughout their lives. Furthermore, anemia with evidence of red blood cell fragmentation and thrombocytopenia were present chronically. Periodical transfusion offrozen fresh plasma prevented recurrent episodes. These cases suggest that there is a congenital variant of thrombotic thrombocytopenic purpura. (Internal Medicine 33: 752-758, 1994) 
Introduction
Thrombotic thrombocytopenic purpura (TTP) , first described by Moshcowitz in 1924 (1) , is characterized by a pentad of clinicalmanifestations including microangiopathic hemolytic anemia,thrombocytopenia, fever, fluctuating neurological signs and renal dysfunction.
Until the early 1960s, TTP had been a fulminant,fatal disease and fewer than five percent of patients with acute episodes survived (2) . Once the efficacy of whole blood exchange transfusions, plasma infusions, or plasma exchanges had been demonstrated, the survival rate of TTP increasedto about eighty percent (3) (4) (5) (6) (7) . It was also revealed that a considerable number of patients who survive the first episode of the disease frequently relapse (8).
This report presents two siblings affected by an unusual variant of TTP. Both siblings have suffered from frequent episodes of TTP with clinical manifestations of headache, vomiting,drowsiness and dark urine since early childhood. The clinicalsymptoms were temporarily improved by whole blood orplasma infusions. Once the diagnosis ofTTP was made, they receivedplasma transfusions to supplement the missing plasma factor. Periodical transfusions of fresh frozen plasma (FFP) controlledtheir disease. Reports of siblings affected by chronic relapsingTTP since early childhood are quite rare because TTP was usually a fulminant and fatal disease. The present cases mayrepresent an important variant of the disease.
Case Report

Case1
A 10-year-old Japanese boy was admitted to the Yamaguchi University Hospital on the 20th of August 1990. He was born after an uncomplicated 38-week pregnancy with a birth weight of3,030 g to 30-year-old, gravida 2, para 2 mother. Thirty-eight hours after birth he received exchange transfusions because of Five days after admission, he complained suddenly of headache and general fatigue, followed by drowsiness, dark urine and fever.
As before, there was no apparent precipitating factor. Neurological examination revealed no abnormality associated with the drowsiness. The urine was "Coca-Cola"-like in color and contained hemoglobin and protein. Microscopic examination of the urine revealed no white blood cells, a few red blood cells and many red blood cell casts. Six hours after the onset of this episode, we initiated a 200 ml fresh frozen plasma (FFP)
transfusion. When one half of the volume of FFP was trans- spherocytosis, reticulocytosis and fragmentation in the peripheral blood smear of case 1 (A) and case 2 (B). The milder morphological changes were seen in the second sister, who had no episodes of TTP (C) (Wright stain, x600).
fused, his consciousness level improved dramatically, as headache and general fatigue disappeared at once. The urine was no longer dark at 6 hours after initiating the FFP. The body temperature rose to 38.2°C at 6 hours after the onset of the episode and then fell rapidly. The platelet count began to increase beginning at 24 hours after FFP infusion, reached a peak of 126xlO9/l at 5 days after FFP, and decreased gradually thereafter. The hemoglobin level, which decreased to 5.9 g/dl from 7.8 g/dl during this episode, also began to increase beginning at 24 hours after FFP infusion to reach the peak of 1 0.9 g/dl at 7 days after FFP, and thereafter decreased gradually (Fig. 2) the maximum response rate of adenosine diphosphate (3 |LiM) was 17%, epinephrine (3 jLig) was 10%, and collagen (2 jag) was 0%.
Although the clinical course suggested a chronic active course, the patient has not had any significant clinical symptom since January 1991 and appears to be very well as of December 1993.
Case2
A 4-year-old girl, the younger sister of patient 1, was admitted to our hospital on the same day as patient 1. She was born in 1986 after an uncomplicated 38-week pregnancy with a birth weight of 2,782 g. The patient received exchange transfusions on the first and the second days after birth because ofhyperbilirubinemia.
From the age of 8 months to 4 years, she experienced 8 episodes characterized by preceding upper respiratory infection associated with high fever, followed by headache, general fatigue, drowsiness and dark urine. Each episode was treated with 100 ml or 200 ml of whole blood orpacked red cells and some antibiotics providing dramatic relief from her clinical symptoms. However, abnormalities in the peripheral blood counts and the abnormal appearance of the red cells persisted even during asymptomatic periods as in case 1. On admission, physical examination revealed a well developed, well nourished, slightly pale girl, exhibiting several ecchymoses on the extremities.
No evidence of hepatosplenomegaly, lymphadenopathy, jaundice, hypertension, neurological abnormalities, or renal insufficiency was observed. The laboratory data are summarized in Table 1 , and are similar to those abnormalities seen in case 1. The red blood cell morphology was also abnormal as there was anisocytosis, poikilocytosis, spherocytosis, reticulocytosis and fragmentation (Fig.  I B) . The urine was weakly positive for occult blood and negative for protein. A bone marrow aspirate revealed hyperplasia with a 0.5:1 of myeloid to erythroid ratio and numerous megakaryocytes.
Studies of red blood cell osmotic fragility and activities of enzymes in the red cells were normal and no abnormal hemoglobin was evident. The platelet aggregation Wehad no opportunity to observe any episode in the hospital. The laboratory data, however, demonstrated clearly that the patient had a chronic active disease resembling TTP as did her elder brother.
We resigned to give prophylactic transfusions of FFP because we could not obtain her parents' consent. She was discharged with her elder brother (case 1) on the 1 st of September, 1990. At 6 months after discharge, she had a relatively severe episode associated with an intracranial hemorrhage. After that, she received preventive transfusions of 100 ml FFP and has not since experienced any similar episode. Thus, we concluded that both siblings had the same disease, a variant of The two affected siblings were born into a family of four children (Fig. 4) . The eldest sister died at 4 days after birth with a diagnosis of''Melena neonatorum''. The details ofherperinatal health could not be obtained, but suggested that she too had TTP. The second sister, a 14-year-old, has had no episode of TTP and has normal peripheral blood counts and normal blood chemistries. However, a low serum haptoglobin level (34 mg/ dl), mild poikilocytosis and red blood cell fragmentation in this subject suggests a mild variant of TTP (Fig. 1C) . The parents were unrelated and had no history of anemia, thrombocytopenia orjaundice. Screening tests of the parents, including peripheral blood counts, blood chemistries, and serum haptoglobin levels revealed no abnormality.
The other family members were not examined. Human leukocyte antigen (HLA) typing was performed for subjects 1 and 2 and their mother and revealed that they shared at least DR4.
Discussion
Among a number of reports regarding thrombotic microangiopathic hemolytic anemia designated as TTP, hemolytic uremic syndrome (HUS), and other pathogenic microvascular thrombotic conditions, a very unusual subset of a congenital variant has also been reported by several investigators. Schulman and his associates reported a female patient who had frequent episodes of severe epistaxis, purpuric skin lesions, jaundice and precipitous thrombocytopenia usually preceded by an infection (9, 10). They disclosed marked improvement by plasma transfusion of the platelet count as it ceased the hemorrhaging during each episode in this patient. Thereafter, on a trial basis they transfused plasma at regular intervals of 20 to 23 days, and were able to eliminate the hemorrhagic manifestations.
It was noted that the patient had a chronic active disease ofthrombotic microangiopathic hemolytic anemia throughout her life time, even when she was not experiencing an acute episode. Upshow reported a female patient who experienced 32 episodes from the age of 6 months to 1 1 years, which were characterized by high fever, generalized petechial rash, thrombocytopenia, hemolytic anemia and, usually, a prior clinically evident infection although 5 of the 32 episodes occurred spontaneously (1 1). Shinohara et al presented a Japanese female patient with recurrent episodes of petechial bleeding, thrombocytopenia and anemia due to microangiopathic hemolytic anemia ( 1 2). These three patients had several important, commoncharacteristics that were documented clinically and on laboratory analysis, such as onset during infancy, chronic active disease with frequent episodes of thrombotic microangiopathic hemolytic anemia, and an excellent reproducible response to each plasma transfusion. Rennard and Abe proposed the name "Upshow-Schulman syndrome" f or the disease condition exemplified by these subjects (13). The cases described presently are very similar and probably identical to the three patients reported previously.
In case 1 of the present report, however, there were several unique clinical manifestations. The first was the presence ofneurological signs, such as headache, vomiting and drowsiness during each episode, suggesting the occurrence ofmicrothrombi on intracranial vascular lesions as evidenced indirectly by increased theta wave activity on the electroencephalogram. The second was the presence of dark urine during each episode, direct proof of massive intravascular hemolysis. Schulman et al described microscopic hematuria in their patient (9). The third unique feature was the absence of any precipitating factor or premonitory symptom by which we could predict an episode. Although the first several episodes in case 1 were preceded by an upper respiratory infection, the most recent episodes had no apparent precipitating event. Furthermore, in contrast to Upshow's patient who had compensated hemolysis between episodes, the abnormal appearance of red cells in the present case 1 did not improve during symptom-free intervals. Again, the peaks of the platelet count were almostalways below normal in case 1 , while in the three patients reported previously, reactive thrombocytosis was seen after plasma infusions. The disease in case 2 appeared to be milder than in case 1, although the laboratory data demonstrated that active disease was present in both. Historical considerations suggest that patient 2 is at an early phase of a disease identical to that seen in case 1. We expect that she will follow a progressive clinical course similar to that seen in case 1. Indeed, she experienced an intracranial hemorrhage within 6 months of discharge. Although there are several unique clinical characteristics in our sibling cases distinct from those of the three patients described previously, we conclude that our cases can be diagnosed as having "Upshow-Schulman syndrome", a congenital variant of TTP. There are some other case reports probably belonging to "Upshow-Schulman syndrome" in the previous literature. If the patient does not survive the first few attacks, it is not possible to document its chronic clinical course. Elias et al presented three siblings, at least one of which was affected by "the chronic fatal variant ofTTP" who died before the age of two years (14). Wallace et al reported four siblings affected with fatal TTP from early childhood (15). Kaplan et al also reported three HUS siblings with onset during infancy, all of which died before the age of one year (16). These patients appeared to have been affected from birth by chronic thrombotic microangiopathic hemolytic anemia. These patients may be included in the disease category of "Upshow-Schulman syndrome". (29) as demonstrated by the present cases. It is of interest that the parents appear normal although genetic predisposition is suggested. A single autosomal recessive segregation may be causative as speculated by Wallace et al to explain how 4 children of 7 with normal parents were affected (15). In the present cases , however, all four children were somehow affected. Therefore, it is unlikely that a single autosomal recessive mutation is responsible for their condition. Our cases suggest the possibility that environmental factors may operate in addition to a genetic factor. To exclude any environmental factor, such as a toxic agent, we carefully obtained the history of each family member but did not find any prominent characteristics. The mother had no unusual history of drug use. Thus, the fact that our cases are siblings and were affected from infancy suggests ambiguously a genetic cause to their condition. Recently, Byrnes and Moake classified TTP into three subgroups, mainly according to the frequency of episodes; single episode, intermittent and chronic relapsing TTP (30). Interestingly, Rose and Eldor suggested using their unique scoring system that the episodes in frequently relapsing patients were milder than those in patients with a single episode ofTTP (8). The present subjects also have normal renal function, which is the most important prognostic factor in TTP and HUS (3 1), in spite of frequent episodic hemoglobinuria. Furthermore, our patients have experienced neither growth or mental retardation. In conclusion, we report a congenital variant of TTP, "Upshow-Schulman syndrome" in two siblings. Periodical transfusions of FFP were effective for preventing recurrences. Although the present cases suggest that there is a genetic basis for this disease, an etiologic mechanism remains to be clarified. It will be important to follow carefully the clinical course of these patients as it may provide added insight into the pathogenesis
